BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

4:56 PM
May 09, 2008
 |  BC Extra  |  Clinical News

Orexigen off after reporting SAE

Orexigen (NASDAQ:OREX) fell $0.84 to $9.14 on Friday after reporting late Thursday the occurrence of a single serious adverse event (SAE) in a double-blind Phase IIb trial of

Read the full 129 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >